Furthermore, it has been reported that treatment with beta-adrenergic antagonists significantly suppresses the expression of p-ERK, Akt, Bcl-2, and cyclin D1, and induces the activation of caspase-3, caspase-9, and Bax in cultured pancreatic cancer cells [19]. This evidence concerns the gene CASP3 and pancreatic neoplasm.